- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 7 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 5 residues within 4Å:- Chain A: L.182, S.183, H.185
- Chain C: R.170, H.185
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:S.183
- Salt bridges: A:H.185, C:R.170, C:H.185
SO4.3: 3 residues within 4Å:- Chain A: W.147, P.153, K.154
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.154
SO4.6: 5 residues within 4Å:- Chain B: R.170, H.185, W.187
- Chain D: L.182, H.185
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain D- Salt bridges: B:R.170, B:H.185, D:H.185
- Hydrogen bonds: D:L.182
SO4.7: 6 residues within 4Å:- Chain B: L.182, S.183, H.185
- Chain D: R.170, H.185, W.187
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain B- Salt bridges: D:R.170, D:H.185, B:H.185
SO4.8: 3 residues within 4Å:- Chain B: W.147, P.153, K.154
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.154
- Salt bridges: B:K.154
SO4.11: 6 residues within 4Å:- Chain A: R.170, H.185, W.187
- Chain C: L.182, S.183, H.185
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain C- Salt bridges: A:R.170, A:H.185, C:H.185
SO4.12: 3 residues within 4Å:- Chain C: W.147, P.153, K.154
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:K.154
- 4 x GN2: (2~{S})-5-(2-chlorophenyl)sulfanyl-2-(4-morpholin-4-ylphenyl)-4-oxidanyl-2-thiophen-3-yl-1,3-dihydropyridin-6-one(Non-covalent)
GN2.4: 14 residues within 4Å:- Chain A: R.98, N.137, L.164, D.165, R.168, H.192, G.193, V.234, A.237, Y.238, I.241, G.245, T.247
- Ligands: NAD.1
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.234, A:A.237, A:I.241, A:I.241
- Hydrogen bonds: A:R.98, A:N.137, A:R.168, A:R.168
- pi-Stacking: A:Y.238
GN2.9: 14 residues within 4Å:- Chain B: R.98, N.137, L.164, D.165, R.168, H.192, G.193, D.194, A.237, Y.238, I.241, G.245, T.247
- Ligands: NAD.5
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:A.237, B:I.241, B:I.241
- Hydrogen bonds: B:R.98, B:N.137, B:R.168, B:R.168, B:T.247
- pi-Stacking: B:Y.238
GN2.13: 15 residues within 4Å:- Chain C: R.98, N.137, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, G.245, T.247
- Ligands: NAD.10
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:V.234, C:A.237, C:I.241, C:I.241
- Hydrogen bonds: C:N.137, C:R.168, C:R.168
- pi-Stacking: C:Y.238
GN2.15: 15 residues within 4Å:- Chain D: Q.99, N.137, L.164, D.165, R.168, H.192, G.193, D.194, V.234, A.237, Y.238, I.241, G.245, T.247
- Ligands: NAD.14
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:V.234, D:A.237, D:I.241, D:I.241
- Hydrogen bonds: D:N.137, D:R.168, D:R.168, D:T.247
- pi-Stacking: D:Y.238
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Purkey, H.E. et al., Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice. Acs Med.Chem.Lett. (2016)
- Release Date
- 2016-09-14
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 7 x SO4: SULFATE ION(Non-functional Binders)
- 4 x GN2: (2~{S})-5-(2-chlorophenyl)sulfanyl-2-(4-morpholin-4-ylphenyl)-4-oxidanyl-2-thiophen-3-yl-1,3-dihydropyridin-6-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Purkey, H.E. et al., Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice. Acs Med.Chem.Lett. (2016)
- Release Date
- 2016-09-14
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D